LIMS4: A Drug Target / Disease Biomarker (G100288695)

Target Name: LIMS4

NCBI ID: G100288695

LIMS4

LIMS4: A Drug Target / Disease Biomarker

LIMS4, also known as LIPA, is a protein that is expressed in various tissues throughout the body. It is a key regulator of lipid metabolism and has been implicated in the development and progression of various diseases, including obesity, type 2 diabetes, and cardiovascular disease.

Recent studies have identified LIMS4 as a potential drug target for the treatment of these diseases. By inhibiting the activity of LIMS4, researchers have found that they can reduce the production of fat in the body and improve insulin sensitivity, which can lead to better management of type 2 diabetes and other related conditions.

One of the unique features of LIMS4 is its ability to interact with multiple cellular signaling pathways. This makes it a versatile target for drug development. Researchers have identified multiple mechanisms by which LIMS4 can contribute to the development of diseases, including the regulation of inflammation, cellular stress, and metabolism.

One of the most promising aspects of LIMS4 as a drug target is its potential to address a wide range of diseases, from obesity and type 2 diabetes to cardiovascular disease and neurodegenerative disorders. Obesity, in particular, is a major public health issue that is associated with a range of negative consequences, including increased risk of cardiovascular disease, diabetes, and certain cancers.

In addition to its potential as a drug target, LIMS4 is also a valuable biomarker for the diagnosis and monitoring of various diseases. For example, studies have shown that levels of LIMS4 are elevated in individuals with obesity and that they are associated with an increased risk of developing type 2 diabetes.

In conclusion, LIMS4 is a protein that has the potential to be a valuable drug target for the treatment of a wide range of diseases. Its unique ability to interact with multiple cellular signaling pathways makes it an attractive target for drug development, and its potential as a biomarker for disease assessment makes it an important area of research. Further studies are needed to fully understand the role of LIMS4 in disease and to develop safe and effective treatments.

Protein Name: LIM Zinc Finger Domain Containing 4

The "LIMS4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LIMS4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets